Latest News & Features
Asia
On August 8 the IPAB revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan. 12 August 2013
Americas
Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims. 8 August 2013
Asia
The Kolkata Patent Office has refused divisional patents related to Swiss pharmaceutical company Roche’s breast cancer drug Herceptin. 7 August 2013
article
Eversheds has appointed the former head of Sidley Austin's London IP and life sciences team Brett Rowland, as a partner. 6 August 2013
Big Pharma
On August 5, Swiss pharmaceutical company Roche signed an agreement with the MPP to increase access to its drug valganciclovir (Valcyte), an oral medicine for the treatment of preventable viral infection cytomegalovirus (CMV). 5 August 2013
Asia-Pacific
The Intellectual Property Appellate Board in Chennai has cancelled two trademarks associated with versions of Viagra. 2 August 2013
Asia
India’s Intellectual Property Appeal Board has revoked a patent covering GlaxoSmithKline’s breast cancer drug Tykerb, in the latest blow to western pharmaceutical companies in India. 2 August 2013
Europe
The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid. 1 August 2013
Americas
Gabriel Di Blasi outlines the existing impediments to developing new biotechnology products in Brazil,
and considers recent efforts to improve the situation. 31 July 2013
Europe
At some offices, the passage of a patent through the system is not quite as fast as applicants might hope—and at others it may be quicker than they would like. Matt Smith and Jonathan Wills outline the situation. 31 July 2013